Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Dog Vaccines Market Growth in 2025?

The market for dog vaccines has witnessed significant expansion in recent years. The market size is projected to increase from $3.61 billion in 2024 to $3.81 billion in 2025, marking a compound annual growth rate (CAGR) of 5.5%. The historical growth is attributed to innovative vaccine procedures, awareness of zoonotic diseases, globalization and travel, educational drives, research and the development of new vaccines, and the progress in veterinary practices.

What Is the Forecast for the Dog Vaccines Market Size Through 2029?

The market size for dog vaccines is projected to witness significant expansion in the coming years, with an expected value of $5.08 billion in 2029, compounding at an annual growth rate of 7.5%. Factors contributing to this growth in the prediction period include elevated pet adoption rates, increased health awareness among pet owners, government laws and directives, the escalating trend of treating pets as family members, and the widespread existence of canine diseases. Major upcoming trends encompass pet insurance and healthcare provisions, ease of availability and accessibility, personalized vaccination procedures, evolving disease trends, and the creation of new vaccines.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=8443&type=smp

What are the Key Market Players in Dog Vaccines Market and How They’re Evolving?

Major companies operating in the dog vaccines market are Vetoquinol S.A., Boehringer Ingelheim GmbH, Ceva Sante Animale, Heska Corporation, Merck & Co. Inc., Virbac Animal Health Pvt. Ltd., Elanco Animal Health Incorporated, Zoetis Inc., CZ Vaccines, Indian Immunologicals Ltd., Meiji Holdings Co. Ltd., Bioveta A.S., Phibro Animal Health Corporation, Hester Biosciences Limited, High Speed Digieal Processor Architecture Pvt. Ltd., Dechra Pharmaceuticals PLC, Norbrook Inc., Biogenesis Bago SA, Vaxxinova India Private Limited, Bimeda Animal Health Ltd., Lohmann Animal Health GmbH, Biovac Ltd., Zenex Animal Health India Pvt. Ltd., Instituto Rosenbusch S A

What Are the Primary Growth Drivers in the Dog Vaccines Market?

The surge in pet dog adoption is predicted to push forward the dog vaccines market. Pet dogs are essentially companion animals that have been domesticated or tamed, residing within households. A dog vaccine is a series of injections administered from the puppy stage and carried into the animal’s adult life. The objective of this vaccine is to stimulate the immune system to equip dogs to deal with microorganisms without falling gravely ill or experiencing severe symptoms. As per the 2021-2022 National Pet Owners Survey by the American Pet Products Association, a non-profit industry association based in the US, pet ownership extends to 70% of households, equating to approximately 90.5 million homes. Among these, 69 million U.S. households keep dogs as pets, positioning them at the top compared to other pet animals. Hence, with the increase in pet dog adoption, the dog vaccines market is experiencing considerable growth.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=8443&type=smp

What Are the Leading Segments in the Global Dog Vaccines Industry?

The dog vaccines market covered in this report is segmented –

1) By Type: Attenuated Live Vaccines, Conjugate Vaccines, Inactivated Vaccines, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines, Recombinant Vaccines

2) By Route Of Administration: Subcutaneous, Intramuscular, Intranasal

3) By Application: Below 6 Months, Above 6 Months

Subsegments:

1) By Attenuated Live Vaccines: Canine Parvovirus Vaccine, Canine Distemper Vaccine, Canine Adenovirus Vaccine

2) By Conjugate Vaccines: Canine Leptospira Vaccine, Canine Bordetella Vaccine

3) By Inactivated Vaccines: Canine Parvovirus Vaccine, Canine Influenza Vaccine

4) By Subunit Vaccines: Canine Lyme Disease Vaccine, Canine Parainfluenza Vaccine

5) By Toxoid Vaccines: Canine Leptospirosis Toxoid Vaccine

6) By DNA Vaccines: Canine Melanoma Vaccine

7) By Recombinant Vaccines: Canine Lyme Disease Recombinant Vaccine, Canine Bordetella Recombinant Vaccine

What Are the Key Market Trends in the Dog Vaccines Industry?

The emergence of innovative technologies is becoming a prominent trend in the dog vaccines industry. Major corporations involved in the dog vaccines sector are moving towards leveraging groundbreaking technologies for vaccine creation. Take Merck Animal Health for example, a U.S.-based firm that offers veterinary drugs, vaccines, and tech solutions, launched Nobivac Intra-Trac Oral BbPi, the inaugural oral vaccine that provides mucosal protection and easy oral dosing, in September 2022. It is designed for the immunization of healthy dogs as young as 7 weeks against the canine parainfluenza virus and Bordetella bronchiseptica. Moreover, it incorporates the unique technology, Immuno-Mist-R technology by Intervet, a subsidiary of Merck & Co. This game-changing tech, Immuno-Mist-R™, significantly enhances the contact with the mucosal surface area.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/dog-vaccines-global-market-report

What Is the Regional Outlook for the Dog Vaccines Market?

Asia-Pacific was the largest region in the dog vaccines market in 2024. The regions covered in the dog vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=8443

This Report Delivers Insight On:

1. How big is the dog vaccines market, and how is it changing globally?

2. Who are the major companies in the dog vaccines market, and how are they performing?

3. What are the key opportunities and risks in the dog vaccines market right now?

4. Which products or customer segments are growing the most in the dog vaccines market?

5. What factors are helping or slowing down the growth of the dog vaccines market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 2071930708

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model